secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2026-06-30T20:19:25+00:00
Accession:  0001213900-26-073709
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oramed extends Scilex payment obligations; receives $0.5M, $5M due July 31
--------------------------------------------------------------------------

- Scilex owes ~$29.5M on Tranche A Note and ~$6.7M on Tranche B Note amortization as of June 30, 2026.
- Extension agreement: Scilex pays $0.5M (received), $5M by July 31, 2026, balance by Sept 30, 2026.
- First $1M received is extension fee; if Scilex fails by Sept 30, first $1.5M becomes non-refundable fee.
- If Scilex defaults, remaining obligations may be satisfied via delivery of Scilex common shares.
- Bylaws amended to revise record date procedures for stockholder action by written consent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390026073709/0001213900-26-073709-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390026073709/ea0296520-8k_oramed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-073709

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer